ANI Pharmaceuticals, Inc. (ANIP) Soars to 52-Week High, Time to Cash Out?Zacks Investment Research • 04/17/25
ANI Pharmaceuticals to Discuss First Quarter 2025 Financial Results on May 9, 2025, at 8:00 a.m. ETGlobeNewsWire • 04/09/25
Tariff Woes? Play Safe With 4 Low-Beta Stocks: ANIP, EXE, AVA & CTGOZacks Investment Research • 04/07/25
Is the Options Market Predicting a Spike in ANI Pharmaceuticals (ANIP) Stock?Zacks Investment Research • 04/03/25
ANI Pharmaceuticals to Present at 2025 RBC Capital Markets Ophthalmology Virtual ConferenceGlobeNewsWire • 03/31/25
Wall Street Analysts Think ANI (ANIP) Could Surge 26.83%: Read This Before Placing a BetZacks Investment Research • 03/24/25
ANI Pharmaceuticals Announces Buyout of Royalty Obligation for ILUVIEN® and YUTIQ®GlobeNewsWire • 03/18/25
Wall Street Analysts Believe ANI (ANIP) Could Rally 32.4%: Here's is How to TradeZacks Investment Research • 03/07/25
ANI Pharmaceuticals Announces FDA Approval of New Purified Cortrophin Gel® Prefilled SyringeGlobeNewsWire • 03/03/25
ANI Pharmaceuticals Expects Strong Start To 2025, On Back Of Cortrophin Gel And Generics, Lifts Annual ForecastBenzinga • 02/28/25
ANI (ANIP) Q4 Earnings: Taking a Look at Key Metrics Versus EstimatesZacks Investment Research • 02/28/25
ANI Pharmaceuticals Reports Record Fourth Quarter and Full-Year 2024 Financial Results and Raises 2025 GuidanceGlobeNewsWire • 02/28/25
ANI Pharmaceuticals to Present at Raymond James' Institutional Investors and Leerink Partners Global Healthcare Conferences in MarchGlobeNewsWire • 02/19/25
ANI Pharmaceuticals to Discuss Fourth Quarter and Full Year 2024 Financial Results on February 28, 2025, at 8:00 a.m. ETGlobeNewsWire • 02/18/25